Works citing this work

3 works

Work: Phase 3 Trial of ¹⁷⁷ Lu-Dotatate for Midgut Neuroendocrine Tumors

1. Theranostics in nuclear medicine practice

   Anna Yordanova, Elisabeth Eppard, Stefan Kürpig +6

   Review articleNeuroendocrine Tumor Research AdvancesOncoTargets and Therapy20170 citations

   ABIABI:AkademIndex/openalex/2017.review-article.000002

2. Preparation of a lyophilized kit based on the DOTA-TATE peptide ligand and the high-specific-activity radiopharmaceutical “[177Lu]Lu-DOTA-TATE, for injection”

   Zafar Usarov, S. Khujaev, L. O. Xajiyev

   ArticleNeuroendocrine Tumor Research AdvancesInteractions20260 citations

   ABIABI:AkademIndex/openalex/2026.article.013036

3. Comparison of Total Body Irradiation and Lu-177-DOTATATE Therapy in Pediatric Neuroblastoma: A Dosimetric Analysis of Organ-Specific Radiation Doses

   Sevgi Ölmez

   PreprintNeuroblastoma Research and TreatmentsResearch Square20260 citations

   ABIABI:AkademIndex/openalex/2026.preprint.001203